1279 related articles for article (PubMed ID: 23978556)
1. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B; Lu CH; Greensmith L
Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
[TBL] [Abstract][Full Text] [Related]
2. Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models.
Kuta R; Larochelle N; Fernandez M; Pal A; Minotti S; Tibshirani M; St Louis K; Gentil BJ; Nalbantoglu JN; Hermann A; Durham HD
Cell Stress Chaperones; 2020 Jan; 25(1):173-191. PubMed ID: 31900865
[TBL] [Abstract][Full Text] [Related]
3. Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis.
Phukan J
IDrugs; 2010 Jul; 13(7):482-96. PubMed ID: 20582873
[TBL] [Abstract][Full Text] [Related]
4. Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1 mouse model of ALS.
Kalmar B; Novoselov S; Gray A; Cheetham ME; Margulis B; Greensmith L
J Neurochem; 2008 Oct; 107(2):339-50. PubMed ID: 18673445
[TBL] [Abstract][Full Text] [Related]
5. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice.
Kieran D; Kalmar B; Dick JR; Riddoch-Contreras J; Burnstock G; Greensmith L
Nat Med; 2004 Apr; 10(4):402-5. PubMed ID: 15034571
[TBL] [Abstract][Full Text] [Related]
6. Arimoclomol: a potential therapy under development for ALS.
Lanka V; Wieland S; Barber J; Cudkowicz M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1907-18. PubMed ID: 19938902
[TBL] [Abstract][Full Text] [Related]
7. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
9. Amplifying the Heat Shock Response Ameliorates ALS and FTD Pathology in Mouse and Human Models.
Ahmed M; Spicer C; Harley J; Taylor JP; Hanna M; Patani R; Greensmith L
Mol Neurobiol; 2023 Dec; 60(12):6896-6915. PubMed ID: 37516663
[TBL] [Abstract][Full Text] [Related]
10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
11. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis.
Chen HJ; Mitchell JC; Novoselov S; Miller J; Nishimura AL; Scotter EL; Vance CA; Cheetham ME; Shaw CE
Brain; 2016 May; 139(Pt 5):1417-32. PubMed ID: 26936937
[TBL] [Abstract][Full Text] [Related]
12. Impact of histone deacetylase inhibition and arimoclomol on heat shock protein expression and disease biomarkers in primary culture models of familial ALS.
Fernández Comaduran M; Minotti S; Jacob-Tomas S; Rizwan J; Larochelle N; Robitaille R; Sephton CF; Vera M; Nalbantoglu JN; Durham HD
Cell Stress Chaperones; 2024 Apr; 29(3):359-380. PubMed ID: 38570009
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive
Benatar M; Wuu J; Andersen PM; Atassi N; David W; Cudkowicz M; Schoenfeld D
Neurology; 2018 Feb; 90(7):e565-e574. PubMed ID: 29367439
[TBL] [Abstract][Full Text] [Related]
14. Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.
Malik B; Nirmalananthan N; Gray AL; La Spada AR; Hanna MG; Greensmith L
Brain; 2013 Mar; 136(Pt 3):926-43. PubMed ID: 23393146
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
16. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
[TBL] [Abstract][Full Text] [Related]
17. Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol.
Deane CA; Brown IR
Cell Stress Chaperones; 2016 Sep; 21(5):837-48. PubMed ID: 27273088
[TBL] [Abstract][Full Text] [Related]
18. Heat shock factor 1 over-expression protects against exposure of hydrophobic residues on mutant SOD1 and early mortality in a mouse model of amyotrophic lateral sclerosis.
Lin PY; Simon SM; Koh WK; Folorunso O; Umbaugh CS; Pierce A
Mol Neurodegener; 2013 Nov; 8():43. PubMed ID: 24256636
[TBL] [Abstract][Full Text] [Related]
19. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
[TBL] [Abstract][Full Text] [Related]
20. Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.
Walker AK; Atkin JD
IUBMB Life; 2011 Sep; 63(9):754-63. PubMed ID: 21834058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
